Novo Nordisk's Ozempic Under Scrutiny For Potential Increased Risk Of Rare-Eye Disease New studies link diabetes drug Ozempic to increased risk of NAION, a rare eye condition causing vision loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback